Paper2964082
Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice.
Field LJ. Science, 1988. Cited by 268 papers, by iCite.
Cite this record
ConductScience Library. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Papers, record 2964082. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2964082
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Polyomavirus Transforming | Major topic |
| Arrhythmias, Cardiac | Major topic |
| Atrial Natriuretic Factor | Major topic |
| Heart Neoplasms | Major topic |
| Animals | |
| DNA, Recombinant | |
| Electrocardiography | |
| Electrophysiology | |
| Genes, Regulator | |
| Heart Atria | |
| Heart Conduction System | |
| Hyperplasia | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Inbred DBA | |
| Mice, Transgenic | |
| Oncogenes | |
| Promoter Regions, Genetic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HL 38605 | NHLBI NIH HHS | United States | R01HL038605 | PubMed and NIH | NIH RePORTER |
| R29HL038605 | NIH | NIH RePORTER |
Cited by67
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 268 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42123513 | Linking Experimental Models to Pathophysiology: Oxidative Stress and DNA Damage in Cardiovascular Diseases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123513 | PubMed |
| 40860356 | Animal and cellular models of atrial fibrillation: a review. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40860356 | PubMed |
| 38891063 | The Impact of Natriuretic Peptides on Heart Development, Homeostasis, and Disease. | Cells | 2024 | https://conductscience.org/library/papers/38891063 | PubMed |
| 38303497 | Therapeutic advances in atrial fibrillation based on animal models. | J Zhejiang Univ Sci B | 2024 | https://conductscience.org/library/papers/38303497 | PubMed |
| 38132169 | Coagulation Factor Xa Has No Effects on the Expression of PAR1, PAR2, and PAR4 and No Proinflammatory Effects on HL-1 Cells. | Cells | 2023 | https://conductscience.org/library/papers/38132169 | PubMed |
| 36009824 | NRSF/REST-Mediated Epigenomic Regulation in the Heart: Transcriptional Control of Natriuretic Peptides and Beyond. | Biology (Basel) | 2022 | https://conductscience.org/library/papers/36009824 | PubMed |
| 32820393 | Adult Cardiomyocyte Proliferation: a New Insight for Myocardial Infarction Therapy. | J Cardiovasc Transl Res | 2021 | https://conductscience.org/library/papers/32820393 | PubMed |
| 32296716 | Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation. | Front Cardiovasc Med | 2020 | https://conductscience.org/library/papers/32296716 | PubMed |
| 31529165 | Cell Cycle-Mediated Cardiac Regeneration in the Mouse Heart. | Curr Cardiol Rep | 2019 | https://conductscience.org/library/papers/31529165 | PubMed |
| 31419437 | A small-molecule LF3 abrogates β-catenin/TCF4-mediated suppression of NaV1.5 expression in HL-1 cardiomyocytes. | J Mol Cell Cardiol | 2019 | https://conductscience.org/library/papers/31419437 | PubMed |
| 30582449 | Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector. | Circ Res | 2019 | https://conductscience.org/library/papers/30582449 | PubMed |
| 30102264 | Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction. | J Vis Exp | 2018 | https://conductscience.org/library/papers/30102264 | PubMed |
| 30030017 | Network-based predictions of in vivo cardiac hypertrophy. | J Mol Cell Cardiol | 2018 | https://conductscience.org/library/papers/30030017 | PubMed |
| 29976685 | New Myocyte Formation in the Adult Heart: Endogenous Sources and Therapeutic Implications. | Circ Res | 2018 | https://conductscience.org/library/papers/29976685 | PubMed |
| 28679668 | Cell models of arrhythmogenic cardiomyopathy: advances and opportunities. | Dis Model Mech | 2017 | https://conductscience.org/library/papers/28679668 | PubMed |
| 27594686 | Complex and interacting influences of the autonomic nervous system on cardiac electrophysiology in conscious mice. | Auton Neurosci | 2016 | https://conductscience.org/library/papers/27594686 | PubMed |
| 26269526 | Cardiac Regeneration and Stem Cells. | Physiol Rev | 2015 | https://conductscience.org/library/papers/26269526 | PubMed |
| 24689023 | Harnessing the power of dividing cardiomyocytes. | Glob Cardiol Sci Pract | 2013 | https://conductscience.org/library/papers/24689023 | PubMed |
| 24587307 | Characterisation of connexin expression and electrophysiological properties in stable clones of the HL-1 myocyte cell line. | PLoS One | 2014 | https://conductscience.org/library/papers/24587307 | PubMed |
| 24561859 | Cardiac electrophysiology and the susceptibility to sustained ventricular tachycardia in intact, conscious mice. | Am J Physiol Heart Circ Physiol | 2014 | https://conductscience.org/library/papers/24561859 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2964082
GET https://conductscience.org/api/papers/v1/2964082/cited_by?page=2